Gilead Sciences is expanding clinical trials of its experimental antiviral drug, remdesivir, for the treatment of COVID-19 into several Asian countries outside China, including Taiwan, the US biotechnology company said in a statement.
Starting next month, the drug is to be tested among 1,000 COVID-19 patients at medical centers across Asia, it said.
The studies would assess two dosing durations of remdesivir, administered intravenously.
Photo: Reuters
One of the trials would randomly enroll about 400 patients with severe clinical manifestations of COVID-19 to receive either five or 10 days of remdesivir, while the second trial would involve about 600 patients with moderate clinical manifestations, who would receive five or 10 days of remdesivir or standard care, the statement said.
Taiwan wanted to bring in the antiviral drug by submitting a request for compassionate use, an option that allows the use of an unapproved drug or medical device for treatment outside of clinical trials, National Taiwan University executive vice president Chang Shan-chwen (張上淳), who also serves in the Central Epidemic Command Center, said on Thursday.
However, the request has not been approved due to strict restrictions on exports of such unauthorized medicine by the US Food and Drug Administration, Chang said.
Only a small quantity of the experimental antiviral drug would be available to patients participating in the clinical trials to evaluate its safety and efficacy, he said, adding that Taiwan has obtained Gilead Sciences’ approval to start local trials along with several other Asian countries.
The US drugmaker is to sign a contract with three hospitals — one each in northern, central and southern Taiwan — to conduct the trials, Chang said.
Taiwan’s hospitals are gearing up for the clinical trials, which are expected to start in the middle of next month at the earliest, he said.
Remdesivir is the only therapy that has shown promise for treating COVID-19.
The Sports Administration yesterday demanded an apology from the national table tennis association for barring 17-year-old Yeh Yi-tian (葉伊恬) from competing in the upcoming World Table Tennis (WTT) United States Smash tournament in Las Vegas this July. The sports agency said in a statement that the Chinese Taipei Table Tennis Association (CTTTA) must explain to the public why it withdrew Yeh from the WTT tournament in Las Vegas. The sports agency said it contacted the association to express its disapproval of the decision-making process after receiving a complaint from Yeh’s coach, Chuang
The Hualien Branch of the High Court today sentenced the main suspect in the 2021 fatal derailment of the Taroko Express to 12 years and six months in jail in the second trial of the suspect for his role in Taiwan’s deadliest train crash. Lee Yi-hsiang (李義祥), the driver of a crane truck that fell onto the tracks and which the the Taiwan Railways Administration's (TRA) train crashed into in an accident that killed 49 people and injured 200, was sentenced to seven years and 10 months in the first trial by the Hualien District Court in 2022. Hoa Van Hao, a
Control Yuan Secretary-General Lee Chun-yi (李俊俋) tendered his resignation last night, admitting that he had misused a government vehicle, as reported by media. His resignation was immediately accepted by the Control Yuan. In a statement explaining why he had resigned, Lee apologized for using a Control Yuan vehicle to transport his dog to a pet grooming salon on May 20. The issue first came to light late last month, when TVBS News reported that Lee had instructed his driver to take the dog to the salon. The news channel broadcast photos that it said were taken by an unnamed whistle-blower, which purportedly showed the
Taipei has once again made it to the top 100 in Oxford Economics’ Global Cities Index 2025 report, moving up five places from last year to 60. The annual index, which was published last month, evaluated 1,000 of the most populated metropolises based on five indices — economics, human capital, quality of life, environment and governance. New York maintained its top spot this year, placing first in the economics index thanks to the strength of its vibrant financial industry and economic stability. Taipei ranked 263rd in economics, 44th in human capital, 15th in quality of life, 284th for environment and 75th in governance,
RSS